Flolan (Epoprostenol)

Epoprostenol is a strong medicine used to treat high blood pressure in the lungs. It helps relax blood vessels, making it easier for blood to flow through the lungs. It's often given through a tube directly into a vein.

Brand names:Flolan, Veletri
Medication

What people taking Flolan (Epoprostenol) report

Every report comes from a Lived member, sent anonymously.

Have you tried Flolan (Epoprostenol) for Pulmonary Arterial Hypertension?

NameHow it went

About Flolan (Epoprostenol)

What It's For

Epoprostenol is a prescription medicine for pulmonary arterial hypertension (PAH), a rare disease in which the small arteries in the lungs narrow and stiffen. Pressure inside those arteries rises, and the right side of the heart has to work harder to push blood through the lungs, which causes breathlessness, tiredness and dizziness. Epoprostenol is approved to improve exercise capacity in PAH. It was studied mainly in people with severe symptoms whose PAH had no known cause, was inherited, or was linked to a connective tissue disease such as scleroderma. Flolan was the original brand. It has since been discontinued in the United States, and the medicine is now available as Veletri and as generic epoprostenol. It is given as a continuous infusion into a vein, so PAH specialists generally reserve it for people whose disease is severe or at high risk of getting worse, usually alongside two kinds of PAH tablets. Needing this kind of infusion is also one of the points at which specialists recommend considering an evaluation for lung transplant. Hospitals also give an inhaled form, off-label, to some critically ill patients with dangerously low oxygen levels or pulmonary hypertension in intensive care. That is a separate, short-term use. In people with acute respiratory distress syndrome who needed a ventilator, inhaled epoprostenol has not been shown to improve survival or shorten time on the ventilator.

How It Works

Prostacyclin is a substance made by the lining of blood vessels. It relaxes the muscle in artery walls and keeps platelets, the blood cells that start clots, from clumping together. Epoprostenol is a manufactured form of prostacyclin. By widening the narrowed lung arteries, it lowers the resistance the right side of the heart pumps against, so the heart can move more blood with each beat. It widens arteries elsewhere in the body too, which explains many of its side effects, such as flushing, headache and low blood pressure. Epoprostenol breaks down within minutes in the blood; its half-life is expected to be no more than about 6 minutes. That is why it has to run continuously, and why stopping the infusion, even briefly, quickly takes its effect away.

Dosage & Administration

Epoprostenol comes as a powder that is mixed with sterile liquid and infused into a vein 24 hours a day. For long-term use it runs through a permanent central venous catheter, a thin tube placed in a large vein in the chest, connected to a small portable pump. A temporary IV in the arm may be used until the central line is in place. Treatment starts in a hospital or specialist center at a very low rate, measured in nanograms per kilogram of body weight per minute, while blood pressure and heart rate are watched closely. The rate is then raised in small steps over weeks to months as symptoms and side effects allow, and most people need further increases over time. Dose changes are made by the PAH team, not on one's own. At home, the person or a caregiver mixes fresh medicine, fills the pump's reservoir and cares for the catheter using strict sterile technique, after training from the care team. How the powder is mixed, how long a prepared reservoir can run and whether it needs to be kept cool differ between Veletri and the generic products, so follow the instructions for the exact product supplied. The medicine comes from a specialty pharmacy rather than a regular one. Because the drug wears off within minutes, a pump failure or a blocked, leaking or disconnected line can bring on breathlessness, dizziness and weakness quickly; in clinical trials, one death was attributed to an interruption. People keep a backup pump and spare supplies with them at all times. If the infusion stops, restart it with the backup right away and call the PAH team. Severe trouble breathing, collapse or fainting is an emergency: call 911.

Side Effects

Most side effects come from blood vessels widening throughout the body. When treatment starts or the dose goes up, flushing, headache, nausea or vomiting and a drop in blood pressure are the most common. With long-term use, headache, jaw pain, diarrhea, flushing, muscle and joint aches, flu-like symptoms and anxiety are common. Some of these ease without any change, while others lead the team to slow the rate. A cluster of flushing, headache, a pounding heartbeat and lightheadedness after a dose change can mean the dose is too high and is worth reporting to the team promptly. The central line carries the most serious risk. Infection where the catheter leaves the skin is common, and bacteria can also reach the bloodstream (sepsis), which can become life-threatening. Fever, chills, or redness, swelling, pain or drainage around the catheter need a call to the PAH team right away. Unusual bleeding or bruising should be reported the same way, and coughing up blood needs urgent medical care.

Interactions & Warnings

Epoprostenol adds to the effect of other medicines that lower blood pressure, including diuretics (water pills), blood pressure medicines and other vasodilators, so combinations can cause dizziness or fainting. Because it reduces platelet clumping, it may also add to bleeding risk with blood thinners such as warfarin or antiplatelet medicines such as clopidogrel. Many people on epoprostenol are deliberately prescribed a blood thinner to lower the risk of clots, and in trials people took both without extra bleeding, so this is a matter for monitoring rather than avoidance. People taking digoxin, a heart medicine, may see their digoxin level rise after starting epoprostenol. The PAH team and pharmacist should know about every prescription, over-the-counter medicine and supplement, and any surgeon or dentist should know about the infusion before a procedure. Epoprostenol is not used long-term in people with heart failure caused by a severely weakened left ventricle, the heart's main pumping chamber: a large trial in that group was stopped early because more people taking epoprostenol died. It is also not continued in someone who develops fluid in the lungs (pulmonary edema) when it is first started, which can signal a related condition called pulmonary veno-occlusive disease. People allergic to epoprostenol should not use it. Limited reports from pregnancy have not shown a clear risk of birth defects or miscarriage, while untreated PAH carries serious risks for both mother and baby, including heart failure, stroke, early delivery and death. Anyone who is pregnant, planning a pregnancy or breastfeeding should discuss it with the PAH team early.

What to Expect

Starting epoprostenol involves placing the central line, beginning the infusion under monitoring and learning to mix the medicine and run the pump. In clinical trials, walking distance, breathlessness and fatigue improved within weeks, sometimes in the first week. In a 12-week study of people with severe PAH that had no known cause or was inherited, 8 of 40 people on standard treatment alone died, compared with none of 41 who also received epoprostenol. The dose keeps being adjusted for months, and follow-up includes regular specialist visits, walking tests and, at times, right heart catheterization, a procedure that measures pressures inside the heart and lungs. Epoprostenol controls PAH but does not cure it, and treatment is usually expected to continue for years. Daily life comes to include mixing the medicine, caring for the line, and always carrying the pump, a backup and supplies, including when traveling. Some people who are doing well later move to treprostinil, a related medicine that can be given under the skin, or to an inhaled or oral prostacyclin-type treatment, often because of line problems or personal preference. These changes are made slowly and with close monitoring, because some people get worse during or after the switch. The dose is never cut sharply or stopped without the team.

Questions to Ask Your Doctor

  1. 1.Why do you recommend epoprostenol for me rather than treprostinil or another treatment?
  2. 2.Which epoprostenol product will I use, and how should I mix, store and carry it?
  3. 3.What should I do, and whom can I reach at any hour, if my pump alarms or the infusion stops?
  4. 4.How will we watch for line infections, and which signs should make me call right away?
  5. 5.How will we judge whether the dose is right, and could I ever move to a treatment that does not need a central line?

Last reviewed • Oct 2026

Educational content, not medical advice.